Pharmacovigilance and Drug Safety

Pharmacovigilance (PV) is defined as the science and events relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem. WHO established that one Programme for International Drug Monitoring in response to the thalidomide disaster detected in 1961.The aims of PV are to enhance patient care and patient safety in relation to the use of medicines.

  • Drug safety
  • Clinical and preclinical trails
  • Bioassay and its types
  • Bioassay and its types
  • Pharmacovigilance and Risk Management

Related Conference of Pharmacovigilance and Drug Safety

July 27-28, 2026

39th World Congress on Pharmacology

Rome, Italy
July 27-28, 2026

19th World Drug Delivery Summit

Paris, France
September 14-15, 2026

6th International Conference on Pharmaceutical Chemistry

Paris, France
September 24-25, 2026

6th World Congress on Rare Diseases & Orphan Drugs

Paris, France
November 26-27, 2026

5th World Conference on Pharma Industry and Medical Devices

Zurich, Switzerland
November 26-27, 2026

5th World Congress on Precision and Personalized Medicine

Zurich, Switzerland

Pharmacovigilance and Drug Safety Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in